Michael Grissinger Aprea Therapeutics, Inc. (APRE) insider trading activity

Michael Grissinger is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 2,889 shares of APRE, which is worth approximately $5,229. The most recent transaction as insider was on Jun 05, 2025, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.89K

56.67% 3M change

261.58% 12M change

Total Value Held $5,229

Michael Grissinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2025	BUY Grant, award, or other acquisition	-	1,045 Added 26.56%	2,889 Common Stock
Jun 20 2024	BUY Grant, award, or other acquisition	-	1,045 Added 36.17%	1,844 Common Stock
Aug 23 2023	BUY Grant, award, or other acquisition	-	500 Added 38.49%	799 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	5,995 Added 50.0%	5,995 Common Stock

Also insider at

AKTX

Akari Therapeutics Plc Healthcare

ACET

Adicet Bio, Inc. Healthcare